IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Artal Group S.A.

Q4 2022 Holdings

Filed 2023-02-13 | 131 holdings | $204.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Sage Therapeutics Inc(SG7)COM78667J108$28.6K750,0000.0%
Allovir IncCOM019818103$28.6K5,577,1670.0%
Karuna Therapeutics IncCOM48576A100$29.5K150,0000.0%
Bellus Health Inc New(BLU)COM NEW07987C204$30.4K3,700,0000.0%
Krystal Biotech Inc(KRYS)COM501147102$31.7K400,0000.0%
Agenus Inc(AGENEUR)COM NEW00847G705$34.8K14,500,0000.0%
IGM Biosciences Inc(1K0)COM449585108$41.7K2,450,0000.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$46.5K900,0000.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$48.8K4,000,0000.0%
Kymera Therapeutics Inc(KYMR)COM501575104$49.9K2,000,0000.0%
Springworks Therapeutics IncCOM85205L107$52.0K2,000,0000.0%
WW Intl Inc(WW6)COM98262P101$57.2K14,818,3000.0%
Morphic Hldg IncCOM61775R105$57.5K2,150,0000.0%
Cerevel Therapeutics Hldng I(CERE1EUR)COM15678U128$59.9K1,900,0000.0%
Scholar Rock Hldg Corp(SRRK)COM80706P103$81.3K8,980,2700.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$83.0K1,832,7580.0%
Lexicon Pharmaceuticals Inc(LXRX)COM NEW528872302$171.5K89,778,2340.1%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$425.0K500,0000.2%
Caribou Biosciences Inc(CRBU)COM142038108$662.0K105,3470.3%
Cardiff Oncology Inc(CRDF)COM14147L108$1.1M750,0000.5%
Adagene Inc(ADAG)ADS005329107$1.3M1,000,0000.6%
Bridgebio Pharma Inc(BBIO)COM10806X102$1.9M250,0000.9%
Cullinan Oncology Inc(CGEM)COM230031106$2.6M250,0001.3%
Black Diamond Therapeutics I(BDTX)COM09203E105$3.0M1,646,5171.4%
Aura Biosciences Inc(AURA)COM05153U107$4.3M410,0002.1%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$4.3M1,000,0002.1%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$5.6M500,0002.8%
Cytokinetics Inc(CYTK)COM NEW23282W605$45.8M1,000,00022.4%
Beigene LTD(ONC)SPONSORED ADR07725L102$132.0M600,00064.5%
PreviousPage 3 of 3